Towards Personalized Medicine By The Early Use Of Patient Data
OPINION Traditional approaches to clinical drug development have created a critical gap between preclinical research and patient applications. Only the drugs that pass big clinical trials reach to the clinic, and a potentially heterogeneous group of patients end up...
Let’s reconsider your research – InnoSer contract breeding services
COVID-19 restrictions brought extra challenges to breeding and maintaining colonies within academic facilities. If you are looking for a service provider resilient to today’s vulnerable environment, InnoSer is here to support you. Let’s put your research back on track...
PDX/O oncology platform developments at InnoSer
Despite the challenging times for the life sciences sector during coronavirus restrictions, we’ve been fortunate enough and well prepared to continue with the development of our PDX/O platform for oncology research. On a weekly basis we receive patient tumor samples...
Press Release: InnoSer continues to deliver critical in-vivo and in-vitro services
Press release | Leiden, 19 March 2020 InnoSer continues to deliver critical in-vivo and in-vitro services COVID-19 restrictions call for attention to prevent fully halting life sciences operations InnoSer remains committed to continuing its in-vivo and in-vitro...
Recent Comments